STOCK TITAN
  1. Home
  2. News
  3. HCAT

Health Catalyst, Inc - HCAT STOCK NEWS

Welcome to our dedicated page for Health Catalyst news (Ticker: HCAT), a resource for investors and traders seeking the latest updates and insights on Health Catalyst stock.

Health Catalyst, Inc. (Nasdaq: HCAT) is a leading provider of data and analytics technology and services to healthcare organizations. Founded by healthcare veterans, the company specializes in building comprehensive data warehousing and process improvement solutions, aiming to significantly enhance healthcare delivery. Health Catalyst's innovative solutions are powered by its adaptive data architecture, which uses a late-binding bus model for agile and quick implementation.

The company operates primarily through two segments: Technology and Professional Services. The Technology segment is the key revenue driver, providing data platforms, analytics applications, and support services under cloud-based subscriptions, time-based licenses, and maintenance agreements. The Professional Services segment offers analytics, implementation, strategic advisory, outsourcing, and improvement services, enabling clients to maximize the utility of Health Catalyst's technological offerings.

Health Catalyst has recently gained recognition with several achievements:

  • VitalCDM: Ranked number one in the Revenue Cycle - Chargemaster Management category of the 2024 Best in KLAS: Software & Services.
  • MeasureAble™: Achieved ONC-Health IT 2015 Edition Certification, allowing its use for various quality reporting programs.
  • Able Health Registry: Received QPP Qualified Registry approval for the 2024 performance year from CMS.
  • Acquisition of Carevive Systems: Strengthened their capabilities in oncology data analytics, improving patient care and outcomes.

Financially, Health Catalyst continues to show promising trends, with forward-looking revenue and EBITDA guidance indicating growth. The company frequently updates its investors through quarterly earnings calls and reports, reflecting transparency and financial health.

Health Catalyst envisions a future where all healthcare decisions are data-informed, leveraging a cloud-based data platform encompassing over 100 million patient records and trillions of data points. This commitment to data-informed decision-making is at the core of its mission to drive measurable improvements in clinical, financial, and operational metrics for healthcare organizations.

For more information, visit the Health Catalyst Investor Relations page.

News

SacValley MedShare Selects Health Catalyst to Power its Qualified Health Information Organization (QHIO)

Rhea-AI Summary
Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations, announced a multi-year partnership with SacValley MedShare, one of California's largest qualified health information organizations. The partnership aims to improve the quality and safety of healthcare by sharing health information securely and efficiently. Health Catalyst will provide a broad set of technology solutions to support SacValley's mission, including KPI Ninja, Healthcare.AI, and other application solutions and Professional Services. The partnership will strengthen interoperability, improve service to payers, and support high-quality reporting and patient care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.83%
Tags
none
-
News

Health Catalyst to Participate in Upcoming Investor Conference

Rhea-AI Summary
Health Catalyst, Inc. (Nasdaq: HCAT) announced participation in the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, with a presentation scheduled on January 10, 2024, at 1:30pm PT. The presentation will feature Dan Burton, CEO, Bryan Hunt, CFO, and Adam Brown, SVP of FP&A and Investor Relations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.78%
Tags
conferences
-
News

Carta Healthcare names Brent Dover CEO

Rhea-AI Summary
Carta Healthcare (Private) announces the appointment of Brent Dover as CEO, triples revenue, and secures a series B funding round of $25 million. The company also received the Health Care of the Future Innovation Award in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.8%
Tags
none
News

Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical Transformation

Rhea-AI Summary
Health Catalyst, Inc. (HCAT) announced that WakeMed Health & Hospitals achieved a $10M variable cost reduction by leveraging Health Catalyst's data and analytics technology to decrease unnecessary care variation and improve care quality. WakeMed's clinical transformation efforts have improved care processes for 23 distinct patient populations, resulting in 37 patients avoiding readmission to the hospital and 17 surgical patients' lives saved. Health Catalyst's CEO, Dan Burton, expressed excitement for WakeMed's success, highlighting the massive, measurable data-informed healthcare improvement realized.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
none
-
News

Health Catalyst to Participate in Upcoming Investor Conferences

Rhea-AI Summary
Health Catalyst, a leading data and analytics provider to healthcare organizations, announced CFO Bryan Hunt and SVP Adam Brown's participation in investor conferences. The Piper Sandler 35th Annual Healthcare Conference in New York on Nov 29, 2023, and the Evercore ISI HealthCONx Conference in Miami on Nov 30, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
conferences
-
News

Health Catalyst to Participate in Upcoming Investor Conference

Rhea-AI Summary
Health Catalyst, Inc. (Nasdaq: HCAT) to participate in Stephens Annual Investment Conference with CFO and Director of FP&A and Investor Relations presenting a fireside chat on November 15, 2023 at 9:00am CT. Replay available online at https://ir.healthcatalyst.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.89%
Tags
conferences
News

Outcome Capital Announces Electronic Registry Systems (ERS) Acquisition by Health Catalyst

Rhea-AI Summary
Health Catalyst, Inc. (HCAT) acquires Electronic Registry Systems, Inc. (ERS) with the help of Outcome Capital, a specialized life science advisory and investment banking firm. ERS is a leading provider of cancer registry solutions and compliance and informatics services, and has distinguished itself with more than 750 cancer center partnerships and longitudinal data covering over 10 million patient records. The acquisition will enable Health Catalyst to further progress in the cancer treatment space by integrating multiple data streams into a single, accessible patient file, addressing the growing cancer burden in the U.S. and more than 100 distinct cancer types.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.5%
Tags
acquisition
-
News

Health Catalyst Reports Third Quarter 2023 Results

Rhea-AI Summary
Health Catalyst, Inc. reported financial results for Q3 2023, with total revenue of $73.8 million and Adjusted EBITDA of $2.0 million, beating quarterly guidance. They raised their full year 2023 revenue guidance range and reiterate their full year 2023 Adjusted EBITDA guidance range. Team member engagement scores measured in the 94th percentile, continuing a pattern of industry-leading engagement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.12%
Tags
earnings
-
News

Accountable Health Partners, A Clinically Integrated Network, Signs Multi-Year Partnership with Health Catalyst to Advance Operational Improvements

Rhea-AI Summary
Health Catalyst announces a multi-year strategic partnership with Accountable Health Partners (AHP), a clinically integrated network (CIN) in the Greater Rochester area. AHP has nearly 3,000 physicians and advanced practice providers and twelve leading hospitals. The partnership will utilize Health Catalyst's data platform and analytics tools to support network reporting and operational needs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.12%
Tags
partnership
News

Health Catalyst Acquires ERS, Bolsters Tech-Enabled Managed Services Offering with Data Abstraction and Oncology Registry Management Capabilities

Rhea-AI Summary
Health Catalyst, Inc. has acquired Electronic Registry Systems, Inc. (ERS), a market leader in cancer registry software and services. ERS provides cancer registry compliance and informatics services through its flagship platform CRStar. The acquisition strengthens Health Catalyst's data abstraction and registry management capabilities, enhancing its Tech-Enabled Managed Services (TEMS) offering in the chart abstraction domain.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.12%
Tags
acquisition

FAQ

What is the current stock price of Health Catalyst (HCAT)?

The current stock price of Health Catalyst (HCAT) is $7.66 as of November 21, 2024.

What is the market cap of Health Catalyst (HCAT)?

The market cap of Health Catalyst (HCAT) is approximately 452.7M.

What does Health Catalyst, Inc. do?

Health Catalyst provides data and analytics technology and services aimed at enhancing healthcare delivery through comprehensive data warehousing and process improvement solutions.

What are the main segments of Health Catalyst's business?

The main segments are Technology, which includes data platforms and analytics applications, and Professional Services, which offers analytics, implementation, strategic advisory, and improvement services.

What recent achievements has Health Catalyst made?

Health Catalyst's recent achievements include the top ranking of VitalCDM in the 2024 Best in KLAS, ONC-Health IT certification for MeasureAble™, QPP Qualified Registry approval for Able Health Registry, and the acquisition of Carevive Systems.

What is the adaptive data architecture?

The adaptive data architecture is a late-binding bus model that provides agility and flexibility, allowing quick implementation of data solutions tailored specifically for healthcare data complexities.

How does Health Catalyst generate its revenue?

Revenue is primarily generated through cloud-based subscription arrangements, time-based licensing, and maintenance and support fees.

What is the Best in KLAS ranking?

Best in KLAS is an annual report that recognizes top-performing software and services companies in healthcare, based on client feedback and evaluations.

What is the significance of the MeasureAble™ ONC-Health IT certification?

The certification allows MeasureAble™ to be used for various quality reporting programs, ensuring compliance with U.S. Department of Health and Human Services standards.

How does the acquisition of Carevive Systems benefit Health Catalyst?

The acquisition enhances Health Catalyst's oncology data analytics capabilities, improving patient care and providing insights into patient-reported outcomes and oncology registry data.

How does Health Catalyst support its clients?

Health Catalyst supports its clients through a combination of advanced data platforms, analytics software, and professional services to drive measurable improvements in clinical, financial, and operational metrics.

Where can I find more information about Health Catalyst's financial performance?

You can find detailed financial information and updates on Health Catalyst's Investor Relations page at https://ir.healthcatalyst.com/.

Stock HCAT logo
Health Catalyst, Inc

Nasdaq:HCAT

HCAT Rankings

#3191 Ranked by Market Cap
N/A Ranked by Dividends

HCAT Stock Data

452.71M
59.17M
2.78%
90.41%
4.67%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States of America
SOUTH JORDAN